MoonLake Immunotherapeutics
MLTX
$39.65
$0.982.53%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -9.29% | -4.98% | -4.98% | 7.05% | 3.03% |
| Total Receivables | 18.12% | 43.55% | 12.09% | 41.54% | 46.63% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 46.51% | 3.76% | 205.71% | 139.72% | -36.50% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -7.42% | -4.58% | -3.02% | 7.67% | 2.83% |
|
|
|||||
| Total Current Assets | -7.42% | -4.58% | -3.02% | 7.67% | 2.83% |
| Net Property, Plant & Equipment | -4.91% | -0.88% | -8.12% | 6.56% | 1,790.52% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -50.00% | -34.65% | -24.99% | -- |
| Total Assets | -7.77% | -4.89% | -3.41% | 7.14% | 5.26% |
|
|
|||||
| Total Accounts Payable | 56.65% | -19.84% | -13.53% | -37.37% | 63.34% |
| Total Accrued Expenses | 12.32% | 80.92% | 56.60% | -21.27% | 12.25% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -5.05% | 9.32% | 1.33% | 8.89% | 666.41% |
| Total Finance Division Other Current Liabilities | 32.53% | -41.57% | -20.66% | 183.99% | -86.66% |
| Total Other Current Liabilities | 32.53% | -41.57% | -20.66% | 183.99% | -86.66% |
| Total Current Liabilities | 11.87% | 63.50% | 37.84% | -10.59% | -3.32% |
|
|
|||||
| Total Current Liabilities | 11.87% | 63.50% | 37.84% | -10.59% | -3.32% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -24.70% | -4.28% | -14.22% | -5.70% | 18,983.97% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -10.69% | 28.25% | 17.12% | -20.69% | 128.43% |
| Total Liabilities | 8.06% | 52.98% | 26.56% | -10.10% | 23.38% |
|
|
|||||
| Common Stock & APIC | 0.31% | 0.50% | 0.27% | 9.87% | 14.81% |
| Retained Earnings | -24.00% | -22.89% | -18.62% | -11.72% | -6.81% |
| Treasury Stock & Other | 76.32% | -12.98% | 20.93% | 14.23% | -18.00% |
| Total Common Equity | -8.47% | -6.24% | -4.03% | 9.46% | 16.65% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -8.47% | -6.24% | -4.03% | 9.46% | 16.65% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -10.13% | -22.01% | -4.73% | -44.81% | -72.47% |
| Total Equity | -8.50% | -6.51% | -4.05% | 7.57% | 4.87% |
|
|
|||||
